Table 3. Results of the cost-effectiveness analysis: costs during treatment.

	Cost impact of capecitabine treatment for colorectal cancer in adjuvant therapy (per patient) £
	Capecitabine	5-FU/LV	Net cost savings
Direct medical costs to the NHS
Cost of chemotherapy drugs	2081	602	−1479
Cost of visits for study drug administration	419	5151	4732
Cost of hospital use	399	459	61
Cost of physician consultations for adverse events	154	145	−9
Cost of medication for treating adverse events	86	345	260
Cost of ambulance trips	38	126	88
Subtotala	3176	6829	3653
Societal costs
Cost of time	319	1503	1184
Cost of travel	62	196	134
Total costsa	3557	8528	4971

^aNumbers may differ because of rounding.